52 related articles for article (PubMed ID: 12120231)
1. Effect of Photofrin-mediated photocytotoxicity on a panel of human pancreatic cancer cells.
Wang LW; Huang Z; Lin H; Li ZS; Hetzel F; Liu Md B
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):244-251. PubMed ID: 23993850
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of human pancreatic cancer cells harboring mutated K-ras to apoptosis.
Shen L; Kim SH; Chen CY
PLoS One; 2012; 7(7):e40435. PubMed ID: 22848379
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of pro-cancer cytokines in the plasma fraction of stored packed red cells.
Benson DD; Beck AW; Burdine MS; Brekken R; Silliman CC; Barnett CC
J Gastrointest Surg; 2012 Mar; 16(3):460-8. PubMed ID: 22246854
[TBL] [Abstract][Full Text] [Related]
4. Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer.
Smith JP; Bingaman SI; Mauger DT; Harvey HH; Demers LM; Zagon IS
Open Access J Clin Trials; 2010 Mar; 2010(2):37-48. PubMed ID: 20890374
[TBL] [Abstract][Full Text] [Related]
5. Membrane proteomic analysis of pancreatic cancer cells.
Liu X; Zhang M; Go VL; Hu S
J Biomed Sci; 2010 Sep; 17(1):74. PubMed ID: 20831833
[TBL] [Abstract][Full Text] [Related]
6. (Pseudo)amide-linked oligosaccharide mimetics: molecular recognition and supramolecular properties.
Jiménez Blanco JL; Ortega-Caballero F; Ortiz Mellet C; García Fernández JM
Beilstein J Org Chem; 2010 Feb; 6():20. PubMed ID: 20485602
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor induces HCCR expression via PI3K/Akt/mTOR signaling in PANC-1 pancreatic cancer cells.
Xu Z; Zhang Y; Jiang J; Yang Y; Shi R; Hao B; Zhang Z; Huang Z; Kim JW; Zhang G
BMC Cancer; 2010 Apr; 10():161. PubMed ID: 20423485
[TBL] [Abstract][Full Text] [Related]
8. Caveolae mediate growth factor-induced disassembly of adherens junctions to support tumor cell dissociation.
Orlichenko L; Weller SG; Cao H; Krueger EW; Awoniyi M; Beznoussenko G; Buccione R; McNiven MA
Mol Biol Cell; 2009 Oct; 20(19):4140-52. PubMed ID: 19641024
[TBL] [Abstract][Full Text] [Related]
9. KAI1 is a potential target for anti-metastasis in pancreatic cancer cells.
Xu JH; Guo XZ; Ren LN; Shao LC; Liu MP
World J Gastroenterol; 2008 Feb; 14(7):1126-32. PubMed ID: 18286698
[TBL] [Abstract][Full Text] [Related]
10. RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells.
Yu C; Zhang X; Sun G; Guo X; Li H; You Y; Jacobs JL; Gardner K; Yuan D; Xu Z; Du Q; Dai C; Qian Z; Jiang K; Zhu Y; Li QQ; Miao Y
J Cell Mol Med; 2008 Dec; 12(6A):2334-49. PubMed ID: 18266952
[TBL] [Abstract][Full Text] [Related]
11. Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes.
Däbritz J; Hänfler J; Preston R; Stieler J; Oettle H
Br J Cancer; 2005 Jan; 92(2):405-12. PubMed ID: 15655549
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile.
Monti P; Marchesi F; Reni M; Mercalli A; Sordi V; Zerbi A; Balzano G; Di Carlo V; Allavena P; Piemonti L
Virchows Arch; 2004 Sep; 445(3):236-47. PubMed ID: 15258755
[TBL] [Abstract][Full Text] [Related]
13. Effects of STI571 (gleevec) on pancreatic cancer cell growth.
Li J; Kleeff J; Guo J; Fischer L; Giese N; Büchler MW; Friess H
Mol Cancer; 2003 Sep; 2():32. PubMed ID: 14521721
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis: targets in pancreatic cancer.
Westphal S; Kalthoff H
Mol Cancer; 2003 Jan; 2():6. PubMed ID: 12605713
[TBL] [Abstract][Full Text] [Related]
15. Implications of growth factor alterations in the treatment of pancreatic cancer.
Juhász M; Nitsche B; Malfertheiner P; Ebert MP
Mol Cancer; 2003 Jan; 2():5. PubMed ID: 12537586
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer: factors regulating tumor development, maintenance and metastasis.
Shi X; Friess H; Kleeff J; Ozawa F; Büchler MW
Pancreatology; 2001; 1(5):517-24. PubMed ID: 12120231
[TBL] [Abstract][Full Text] [Related]
17. Growth factors and their receptors in pancreatic cancer.
Ozawa F; Friess H; Tempia-Caliera A; Kleeff J; Büchler MW
Teratog Carcinog Mutagen; 2001; 21(1):27-44. PubMed ID: 11135319
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer--new aspects of molecular biology research.
Kleeff J; Friess H; Berberat PO; Martignoni ME; Z'graggen K; Büchler MW
Swiss Surg; 2000; 6(5):231-4. PubMed ID: 11077487
[TBL] [Abstract][Full Text] [Related]
19. Signaling pathways in pancreatic cancer.
Reddy SA
Cancer J; 2001; 7(4):274-86. PubMed ID: 11561604
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
